Economic Evaluation of CAR T-Cell Therapies by Site Care for Large B-Cell Lymphomas

Researchers found that the potential availability of CAR T-cell therapies for large B-cell lymphomas with lower adverse event rates that are suitable for outpatient administration may reduce the total costs of care.

Source: CancerNetwork - April 16, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news